Variant report
Variant | nsv979844 |
---|---|
Chromosome Location | chr3:75329875-75346160 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:75343397..75343923-chr3:75600934..75601577,2 | MCF-7 | breast: | |
2 | chr3:75343035..75343810-chr3:75470999..75471871,7 | MCF-7 | breast: | |
3 | chr3:75343455..75344253-chr3:75389889..75390567,2 | MCF-7 | breast: | |
4 | chr3:75308414..75309217-chr3:75343438..75343942,2 | MCF-7 | breast: | |
5 | chr3:75343239..75343917-chr3:75478470..75479360,2 | MCF-7 | breast: | |
6 | chr3:75343052..75344300-chr3:75470848..75471840,6 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370546621 | chr3:75329878-75329879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190741220 | chr3:75329951-75329952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114522220 | chr3:75329975-75329976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113576525 | chr3:75329979-75329980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564836021 | chr3:75329992-75329993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79871787 | chr3:75330095-75330096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141983160 | chr3:75330101-75330102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12492996 | chr3:75330108-75330109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574885762 | chr3:75330134-75330135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542198777 | chr3:75330142-75330143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34815818 | chr3:75330145-75330146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115498533 | chr3:75330173-75330174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575777833 | chr3:75330186-75330187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113276876 | chr3:75330194-75330195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564305192 | chr3:75330201-75330202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528181685 | chr3:75330209-75330210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186567539 | chr3:75330236-75330237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529768221 | chr3:75330239-75330240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112567762 | chr3:75330240-75330241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373679484 | chr3:75330248-75330249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190877936 | chr3:75330306-75330307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182863125 | chr3:75330326-75330327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569109390 | chr3:75330338-75330339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532040197 | chr3:75330343-75330344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539324181 | chr3:75330372-75330373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551614004 | chr3:75330378-75330379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187511193 | chr3:75330398-75330399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535174785 | chr3:75330432-75330433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201719474 | chr3:75330456-75330457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369160448 | chr3:75330457-75330458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs68018781 | chr3:75330491-75330492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112076715 | chr3:75330492-75330493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111617133 | chr3:75330498-75330499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535820637 | chr3:75330535-75330536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201820447 | chr3:75330536-75330537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199980372 | chr3:75330547-75330548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371581596 | chr3:75330548-75330549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201560975 | chr3:75330557-75330558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575910473 | chr3:75330563-75330564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546045609 | chr3:75330565-75330566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145115231 | chr3:75330576-75330577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147596052 | chr3:75330593-75330594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534567665 | chr3:75333600-75333601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565034787 | chr3:75333602-75333603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552754977 | chr3:75333618-75333619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568778034 | chr3:75333632-75333633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574573639 | chr3:75333746-75333747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542797700 | chr3:75333754-75333755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371111052 | chr3:75333773-75333774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555029243 | chr3:75333782-75333783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:75329400-75330600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:75333600-75335600 | Enhancers | NH-A | brain |
3 | chr3:75334400-75334800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr3:75334400-75334800 | Enhancers | NHDF-Ad | bronchial |
5 | chr3:75334400-75334800 | Enhancers | Osteobl | bone |
6 | chr3:75334400-75335600 | Enhancers | NHEK | skin |
7 | chr3:75334800-75335200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr3:75343200-75343400 | Flanking Active TSS | Brain Dorsolateral Prefrontal Cortex | brain |
9 | chr3:75343600-75343800 | Enhancers | NH-A | brain |
10 | chr3:75343600-75344600 | Enhancers | Stomach Mucosa | stomach |
11 | chr3:75344200-75344600 | Enhancers | Liver | Liver |
12 | chr3:75344200-75344600 | Enhancers | Pancreas | Pancrea |
13 | chr3:75344600-75346000 | Weak transcription | Pancreas | Pancrea |
14 | chr3:75346000-75346200 | Enhancers | Pancreas | Pancrea |